Publications by authors named "Esther Lips"

Claim this Profile
C
Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status.
Renée S J M Schmitz, Alexandra W van den Belt-Dusebout, Maartje van Seijen, Ellen A J Verschuur, Frederieke H van Duijnhoven, Esther H Lips

Int J Cancer· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-National Radiomics Validation Using Mammography to Predict Occult Invasion in Ductal Carcinoma in Situ.
Rui Hou, Lars J Grimm, Jeffrey R Marks, Lorraine M King, Thomas Lynch, Esther H Lips

Radiology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Watchful waiting for ductal carcinoma in situ: are we ready to step back?
Esther H Lips, Margot Nieberg, Jelle Wesseling

Eur Radiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.
Charlotta V Mulder, Elisabeth M Jongbloed, Marte C Liefaard, Stavros Makrodimitris, Daan M Hazelaar, Esther H Lips

Breast Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort.
Jim Peters, Merle M van Leeuwen, Nikita Moriakov, Jos A A M van Dijck, Ritse M Mann, Esther H Lips

Br J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features.
Shannon Doyle, Esther H Lips, Eric Marcus, Lennart Mulder, Yat-Hee Liu

EBioMedicine· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conquering Overtreatment of DCIS: Lessons from PRECISION.
Proteeti Bhattacharjee, Esther H Lips, Elinor J Sawyer, E Shelley Hwang, Alastair M Thompson

Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.
Marcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, Hendrik A Messal, Xenia Melillo, Esther H Lips

NPJ Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An early economic evaluation of active surveillance for low-risk ductal carcinoma .
Danalyn Byng, Michael Schaapveld, Esther H Lips, Frederieke H van Duijnhoven, Jelle Wesseling

Future Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts.
Stefan J Hutten, Hendrik A Messal, Esther H Lips, Michael Sheinman, Marta Ciwinska

J Pathol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies.
Donna O Debets, Erik L de Graaf, Marte C Liefaard, Gabe S Sonke, Esther H Lips

iScience· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature.
Sena Alaeikhanehshir, Taiwo Ajayi, Frederieke H Duijnhoven, Coralie Poncet, Ridwan O Olaniran, Esther H Lips

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Sena Alaeikhanehshir, Madelon M Voets, Frederieke H van Duijnhoven, Esther H Lips, Emma J Groen

Cancer Imaging· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
Sena Alaeikhanehshir, Renée S J M Schmitz, Alexandra W van den Belt-Dusebout, Frederieke H van Duijnhoven, Ellen Verschuur, Esther H Lips

Breast Cancer Res Treat· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ.
Marjanka K Schmidt, Esther H Lips, Renée Sjm Schmitz, Ellen Verschuur, Jelle Wesseling

BMJ· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.
Marcelo Sobral-Leite, Simon Castillo, Shiva Vonk, Xenia Melillo, Noomie Lam, Esther Lips

Res Sq· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning.
Witali Aswolinskiy, Enrico Munari, Hugo M Horlings, Lennart Mulder, Giuseppe Bogina, Esther H Lips

Breast Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2 breast cancer.
Donna O Debets, Kelly E Stecker, Anastasia Piskopou, Marte C Liefaard, Jelle Wesseling, Esther H Lips

Cell Rep Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
Renée S J M Schmitz, Alexandra W van den Belt-Dusebout, Karen Clements, Yi Ren, Chiara Cresta, Esther H Lips

BMJ· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights.
Marte C Liefaard, Kat S Moore, Lennart Mulder, Daan van den Broek, Jelle Wesseling, Esther H Lips

Br J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.
Sonja Vliek, Florentine S Hilbers, Erik van Werkhoven, Ingrid Mandjes, Rob Kessels, Esther H Lips

NPJ Breast Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.
Tessa G Steenbruggen, Denise M Wolf, Bram Thijssen, Joyce Sanders, Sten Cornelissen, Esther H Lips

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Archival single-cell genomics reveals persistent subclones during DCIS progression.
Kaile Wang, Tapsi Kumar, Junke Wang, Darlan Conterno Minussi, Emi Sei, Esther H Lips

Cell· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microcalcification crystallography as a potential marker of DCIS recurrence.
Sarah B Gosling, Emily L Arnold, Samantha K Davies, Hannah Cross, Ihssane Bouybayoune, Esther H Lips

Sci Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune landscape of breast tumors with low and intermediate estrogen receptor expression.
Leonie Voorwerk, Joyce Sanders, Milou S Keusters, Sara Balduzzi, Sten Cornelissen, Esther H Lips

NPJ Breast Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis